Back to MW MARSHALL WACE, LLP

CNTXCNTX
6 quarters

Position history for MWMARSHALL WACE, LLP's holdings in CONTEXT THERAPEUTICS INC

MARSHALL WACE, LLP holds 384,528 shares of CNTX (CONTEXT THERAPEUTICS INC), worth $211,490 as of 2026-Q2. The position was decreased (-87.0% shares). CNTX represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$211,490

Current Shares

384,528

Total Value Change

-$1,961

Total Shares Change

+181,242

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
384,528
-87.0%
$211,4900.0%$0.55
0
2026-Q1
Increased
2.9M
+13.7%
$7.7M0.0%$2.38
31
2025-Q4
Increased
2.6M
+7153.7%
$3.8M0.0%$1.30
43
2025-Q3
New
35,750
-
$34,6780.0%$0.97
30
2025-Q1
Exited
0
-100.0%
$00.0%$0.65
0
2024-Q4
New
203,286
-
$213,4510.0%$1.06
32

Other major holders of CNTX: FRANKLIN RESOURCES INC, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used